Gene · 8030
Papers1,913
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,913
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Elucidation of genome-wide understudied proteins targeted by PROTAC-induced degradation using interpretable machine learning. | PLoS Comput Biol | 2023 | 37590332 | PubTator, text mining | PubMed |
| Novel insights into molecular patterns of ROS1 fusions in a large Chinese NSCLC cohort: a multicenter study. | Mol Oncol | 2023 | 37584407 | PubTator, text mining | PubMed |
| Resolving the role of podoplanin in the motility of papillary thyroid carcinoma-derived cells using RNA sequencing. | Comput Struct Biotechnol J | 2023 | 37560122 | PubTator, text mining | PubMed |
| Molecular characterization of colorectal adenoma and colorectal cancer via integrated genomic transcriptomic analysis. | Front Oncol | 2023 | 37546388 | PubTator, text mining | PubMed |
| Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex. | J Biol Chem | 2023 | 37536630 | PubTator, text mining | PubMed |
| A Metastatic Pulmonary Sarcomatoid Carcinoma Patient Harboring KIF5B-RET Fusion Responds to First-Line Pralsetinib Treatment: A Case Report. | Cancer Manag Res | 2023 | 37525669 | PubTator, text mining | PubMed |
| Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1. | Mol Ther Nucleic Acids | 2023 | 37520682 | PubTator, text mining | PubMed |
| Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subset. | Transl Oncol | 2023 | 37516008 | PubTator, text mining | PubMed |
| Modulation of Lysosomal Cl- Mediates Migration and Apoptosis through the TRPML1 as a Lysosomal Cl- Sensor. | Cells | 2023 | 37508500 | PubTator, text mining | PubMed |
| E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies. | Front Immunol | 2023 | 37497216 | PubTator, text mining | PubMed |
| Current progress in cancer treatment by targeting FGFR signaling. | Cancer Biol Med | 2023 | 37493315 | PubTator, text mining | PubMed |
| AB-Amy: machine learning aided amyloidogenic risk prediction of therapeutic antibody light chains. | Antib Ther | 2023 | 37492587 | PubTator, text mining | PubMed |
| Small bowel edema and lymphocytic duodenitis as severe reversible gastrointestinal toxicity of selpercatinib in RET fusion-positive non-small cell lung cancer: a case report. | Front Oncol | 2023 | 37492479 | PubTator, text mining | PubMed |
| Diagnostic dilemma in a rare case of nonfunctional parathyroid carcinoma at a referral facility in Northern Tanzania. | Clin Case Rep | 2023 | 37484743 | PubTator, text mining | PubMed |
| Activity of ceritinib in crizotinib-resistant ROS1-rearranged non-small-cell lung cancer patients. | Medicine (Baltimore) | 2023 | 37478263 | PubTator, text mining | PubMed |
| Cytomorphologic, immunophenotypical and molecular features of pancreatic acinar cell carcinoma. | Diagn Cytopathol | 2023 | 37469257 | PubTator, text mining | PubMed |
| Mutational profiling of Chinese patients with thyroid cancer. | Front Endocrinol (Lausanne) | 2023 | 37465126 | PubTator, text mining | PubMed |
| Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort. | Leukemia | 2023 | 37454239 | PubTator, text mining | PubMed |
| Mutational signature dynamics shaping the evolution of oesophageal adenocarcinoma. | Nat Commun | 2023 | 37454136 | PubTator, text mining | PubMed |
| Integrated Clinical, Molecular and Immunological Characterization of Pulmonary Sarcomatoid Carcinomas Reveals an Immune Escape Mechanism That May Influence Therapeutic Strategies. | Int J Mol Sci | 2023 | 37445733 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8030/papers?page=11